STAT+: A promising sickle cell pill and a new way to treat myelofibrosis
Stat a Promising Sickle Cell Pill Shows Improved Efficacy at Higher Dose On the second day of the American Society…
STAT+: ‘Remarkable’ drug results against an aggressive leukemia
STAT Remarkable Drug Results Against Aggressive Leukemia At the recent American Society of Hematology (ASH) meeting, STAT reported on what…
STAT+: Harvard lab hollowed out by Trump cuts
Stat Harvard Lab Hollowed Out by Trump Funding Cuts A renowned computational biology lab at Harvard has been severely impacted…
STAT+: Cancer detection firm Freenome to go public via $330 million SPAC deal
Stat Cancer Detection Firm Freenome Announces Plans to Go Public Freenome, a biotech company based in the Bay Area, is…
STAT+: Vinay Prasad, FDA’s vaccine regulator, waves off criticism in closed-door remarks
STAT Vinay Prasad FDA: Addressing Criticism Amid Vaccine Policy Changes Vinay Prasad, the Food and Drug Administration’s top vaccines regulator,…
STAT+: FDA to lower number of trials required for approval of drugs, other medical products
STAT FDA to Lower Number of Trials Required for Drug Approval The Food and Drug Administration (FDA) plans to reduce…
STAT+: What to expect at the ASH meeting, and some thoughts on the FDA’s Richard Pazdur
Stat What to Expect at the ASH Meeting The ASH meeting is just around the corner, and many are wondering…
STAT+: New data confirm Novo drug did not slow Alzheimer’s progression
STAT New Data Confirm Novo Drug Did Not Slow Alzheimer’s Progression Recent findings have once again shown that the Novo…
STAT+: Hair loss drug succeeds in Phase 3, but data underwhelms experts
Stat Hair Loss Drug Shows Positive Results in Phase 3 Trials A topical hair loss medication demonstrated success in increasing…
STAT+: Aging startup backed by Sam Altman chases $5 billion valuation
Stat Aging Startup Backed by Sam Altman Pursues $5 Billion Valuation Retro Bio, a longevity-focused startup supported by OpenAI CEO…